awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26772331-D7DB5E0D-54DC-40AA-B89C-0E7025BE7163
Q26772331-D7DB5E0D-54DC-40AA-B89C-0E7025BE7163
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772331-D7DB5E0D-54DC-40AA-B89C-0E7025BE7163
Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's Disease
P2860
Q26772331-D7DB5E0D-54DC-40AA-B89C-0E7025BE7163
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772331-D7DB5E0D-54DC-40AA-B89C-0E7025BE7163
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3dba1f517eee6ae5b971fd51e775e36d5516bfd4
P2860
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.